BioNotebook: Interviews with future Raptor CEO Smith, Epirus CEO Munshi; Clinical updates from Alkermes, BioLineRx, Targacept
This article was originally published in Scrip
Executive Summary
Former chief operating officer Julie Anne Smith is now president and CEO-designate of Novato, California-based Raptor Pharmaceuticals as part of a planned leadership transition at the rare disease-focused company.